Sinopec Engineering Group Co Ltd. — Regulatory Filings 2015

Nov 19, 2015

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

UNIVERSE INTERNATIONAL HOLDINGS LIMITED 寰宇國際控股有限公司[*]

(Incorporated in Bermuda with limited liability)

(Stock Code: 1046)

SUPPLEMENTAL ANNOUNCEMENT

Reference is made to the annual report of Universe International Holdings Limited (the “ Company ”, and together with its subsidiaries, the “ Group ”) for the year ended 30 June 2015 published on 28 October 2015 (the “ Annual Report ”).

In compliance with Paragraph 32(4) of Appendix 16 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong (the “ Stock Exchange ”), the Company makes this supplemental announcement to disclose (i) further details in relation to Note 15 (available-for-sale financial assets) and Note 20 (financial assets at fair value through profit or loss) to the consolidated financial statements of the Company on pages 185 to 186 and page 194 of the Annual Report respectively; and (ii) the management discussion and analysis of the investment performance during the year ended 30 June 2015 (the “ Year ”).

AVAILABLE-FOR-SALE FINANCIAL ASSETS

As at 30 June 2015, the available-for-sale financial assets of the Group of approximately HK$88.4 million consists of four investment items in non-listed funds or companies. One of the aforesaid investment items held by the Group, named “Hydra Capital SPC – Class A #1 Share” (“ Hydra Capital ”) valued at approximately HK$63.4 million as at 30 June 2015 which represented (i) approximately 8.6% of the Group’s total asset value as at 30 June 2015 and (ii) approximately 71.7% of the value of the Group’s available-forsale financial assets as at 30 June 2015.

Hydra Capital is an exempted company incorporated with limited liability and registered as a segregated portfolio company under the laws of the Cayman Islands established for the purpose of making investments on behalf of its portfolios where its principal investments are internet related and mobile application in Asia. As at 30 June 2015, the Group held 5,500 shares in Hydra Capital, representing approximately 24.6% of the total issued shares of Hydra Capital of 22,400 shares.

• for identification purposes only

1

FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS

As at 30 June 2015, the dollar value of the financial assets at fair value through profit or loss of the Group of approximately HK$315.1 million is the Group’s investment portfolio and consists of seven investment items, all of which are shares of companies listed on the Stock Exchange. Three of the aforesaid investment items held by the Group, i.e., the shares of (i) Town Health International Medical Group Limited (“ Town Health ”); (ii) China Jicheng Holdings Limited (“ China Jicheng ”); and (iii) Jiu Rong Holdings Limited (“ Jiu Rong ”) valued at approximately HK$80.5 million, HK$79.6 million and approximately HK$71.1 million respectively which represented approximately 10.9%, approximately 10.8% and approximately 9.6% of the Group’s total asset value as at 30 June 2015 respectively and approximately 25.6%, approximately 25.3% and approximately 22.6% of the value of the Group’s financial assets at fair value through profit or loss as at 30 June 2015 respectively. As at 30 June 2015, the total market value of the aforesaid three investment items was approximately HK$231.2 million, representing (i) approximately 31.3% of the Group’s total asset value and (ii) approximately 73.4% of the total financial assets at fair value through profit or loss of the Group respectively.

Town Health and its subsidiaries are principally engaged in (i) healthcare business investments; (ii) provision and management of medical, dental and other healthcare related services; and (iii) investments and trading in properties and securities. As at 30 June 2015, the Group held 38,900,000 shares of Town Health, representing approximately 0.5% of the total issued shares of Town Health of 7,469,631,786 shares.

China Jicheng and its subsidiaries are principally engaged in manufacturing and sale of POE umbrellas and nylon umbrellas and umbrella parts such as plastic cloth and shaft to its customers. As at 30 June 2015, the Group held 38,250,000 shares of China Jicheng, representing approximately 0.3% of the total issued shares of China Jicheng of 15,000,000,000 shares.

Jiu Rong and its subsidiaries are principally engaged in (i) design, assembly and installation of water meter; and (ii) TV business. As at 30 June 2015, the Group held 180,000,000 shares of Jiu Rong, representing approximately 4.7% of the total issued shares of Jiu Rong of 3,800,000,000 shares.

MANAGEMENT DISCUSSION AND ANALYSIS

Securities investments

The Group’s recorded realised and unrealised fair value gain on changes on investment securities of approximately HK$88.9 million (2014: approximately HK$7.9 million) and approximately HK$141.0 million (2014: approximately HK$28.0 million), respectively during the Year. The segment profit of this business is approximately HK$223.7 million (2014: approximately HK$34.1 million) during the Year. Such growth was mainly attributable to the good net performance of our securities investments portfolio and the positive investing market environment during the Year.

During the Year, the Group recorded a realised fair value gain on investment securities of approximately HK$88.9 million (2014: approximately HK$7.9 million). In particular, the disposals of the shares of Suncorp Technologies Limited, a company listed on the Stock Exchange, recorded realised fair value gain of approximately HK$45.0 million contributed to (i) approximately 50.6% of the total realised fair value gain on changes on investment securities of the Group for the Year and (ii) approximately 15% of the revenue and income of the Group for the Year.

2

In addition, the Group recorded unrealised fair value gain on changes on investment securities of approximately HK$141.0 million (2014: approximately HK$28.0 million). The investments in the shares of China Jicheng and Jiu Rong recorded unrealised fair value gain of approximately HK$70.6 million and HK$51.5 million respectively, and together contributed to (i) approximately 86.6% of the total unrealised fair value gain on changes on investment securities of the Group for the Year and (ii) approximately 40.7% of the revenue and income of the Group for the Year.

As at 30 June 2015, all the investment items of the Group’s securities investments portfolio are shares of companies listed on the Stock Exchange and engaged in different industries such as entertainment services, manufacturing, financial advisory business, asset management, solar energy, healthcare and wholesale business etc. The Group will continue diversifying, optimising and consolidating its investment portfolios, so as to achieve a better return to the Group.

By order of the Board Universe International Holdings Limited Lam Shiu Ming, Daneil Chairman and Executive Director

Hong Kong, 19 November 2015

As at the date of this announcement, the executive Directors are Mr. Lam Shiu Ming, Daneil, Mr. Hung Cho Sing, Mr. Yeung Kim Piu and Mr. Lam Kit Sun, the non-executive Director is Mr. Chan Shiu Kwong Stephen, and the independent non-executive Directors are Mr. Lam Wing Tai, Mr. Choi Wing Koon and Mr. Lam Chi Keung.

3